BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24132924)

  • 1. HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.
    Li L; Tang W; Wu X; Karnak D; Meng X; Thompson R; Hao X; Li Y; Qiao XT; Lin J; Fuchs J; Simeone DM; Chen ZN; Lawrence TS; Xu L
    Clin Cancer Res; 2013 Dec; 19(24):6703-15. PubMed ID: 24132924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
    Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice.
    Li L; Hao X; Qin J; Tang W; He F; Smith A; Zhang M; Simeone DM; Qiao XT; Chen ZN; Lawrence TS; Xu L
    Gastroenterology; 2014 Apr; 146(4):1108-18. PubMed ID: 24397969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy
    Fan XY; He D; Sheng CB; Wang B; Wang LJ; Wu XQ; Xu L; Jiang JL; Li L; Chen ZN
    Am J Transl Res; 2019; 11(6):3543-3554. PubMed ID: 31312365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
    Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
    Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.
    Zhu S; Li Y; Mi L; Zhang Y; Zhang L; Gong L; Han X; Yao L; Lan M; Chen Z; Zhang W
    Dig Dis Sci; 2011 Dec; 56(12):3569-76. PubMed ID: 21789540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation.
    Gou X; Ru Q; Zhang H; Chen Y; Li L; Yang H; Xing J; Chen Z
    Cancer Sci; 2009 May; 100(5):837-43. PubMed ID: 19298604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
    Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
    Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.
    Hao J; Madigan MC; Khatri A; Power CA; Hung TT; Beretov J; Chang L; Xiao W; Cozzi PJ; Graham PH; Kearsley JH; Li Y
    PLoS One; 2012; 7(8):e40716. PubMed ID: 22870202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells.
    Dai JY; Dou KF; Wang CH; Zhao P; Lau WB; Tao L; Wu YM; Tang J; Jiang JL; Chen ZN
    BMC Cancer; 2009 Sep; 9():337. PubMed ID: 19775453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression.
    Cui HY; Wang SJ; Song F; Cheng X; Nan G; Zhao Y; Qian MR; Chen X; Li JY; Liu FL; Zhu YM; Tian RF; Wang B; Wu B; Zhang Y; Sun XX; Guo T; Yang XM; Zhang H; Li L; Xu J; Bian HJ; Jiang JL; Chen ZN
    Signal Transduct Target Ther; 2021 Jul; 6(1):268. PubMed ID: 34262017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
    Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
    J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of HAb18G/CD147 in invasion of host cells by severe acute respiratory syndrome coronavirus.
    Chen Z; Mi L; Xu J; Yu J; Wang X; Jiang J; Xing J; Shang P; Qian A; Li Y; Shaw PX; Wang J; Duan S; Ding J; Fan C; Zhang Y; Yang Y; Yu X; Feng Q; Li B; Yao X; Zhang Z; Li L; Xue X; Zhu P
    J Infect Dis; 2005 Mar; 191(5):755-60. PubMed ID: 15688292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner.
    Ma XK; Wang L; Li Y; Yang XM; Zhao P; HaoTang ; Zhu P; Li L; Chen ZN
    BMC Cell Biol; 2010 Apr; 11():27. PubMed ID: 20398401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
    Wang S; Chen X; Tang M
    Oncol Rep; 2014 Dec; 32(6):2824-30. PubMed ID: 25220761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-PI3K-Ca2+ pathways.
    Tang J; Wu YM; Zhao P; Yang XM; Jiang JL; Chen ZN
    Cell Mol Life Sci; 2008 Sep; 65(18):2933-42. PubMed ID: 18695939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-β
    Woods EL; Grigorieva IV; Midgley AC; Brown CVM; Lu YA; Phillips AO; Bowen T; Meran S; Steadman R
    J Biol Chem; 2021 Sep; 297(3):100987. PubMed ID: 34364871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis.
    Zhang DW; Zhao YX; Wei D; Li YL; Zhang Y; Wu J; Xu J; Chen C; Tang H; Zhang W; Gong L; Han Y; Chen ZN; Bian H
    J Hepatol; 2012 Dec; 57(6):1283-91. PubMed ID: 22878468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.